1. Articles in category: Other Cancers

    1-24 of 43 1 2 »
    1. A single center clinical analysis of children with high-risk neuroblastoma.

      A single center clinical analysis of children with high-risk neuroblastoma.

      Oncotarget. 2017 Mar 07;:

      Authors: Tian X, Cao Y, Wang J, Yan J, Tian Y, Li Z, Wang H, Duan X, Jin Y, Zhao Q

      Abstract The current multidisciplinary treatment for patients with high-risk neuroblastoma (NB) is the common census. However, protocols and opinions are different in different regions and institutions.

      Read Full Article
      Mentions: Treatment LDH
    2. Study finds more childhood cancer survivors would likely benefit from genetic screening

      Study finds more childhood cancer survivors would likely benefit from genetic screening

      WASHINGTON, April 3, 2017 /PRNewswire/ -- Twelve percent of childhood cancer survivors carry germline mutations that put them or their children at increased risk of developing cancer, according to a landmark study presented today at the annual meeting of the American Association for...

      Read Full Article
    3. Impact of shared care program in follow-up of childhood cancer survivors: An intervention study

      With the growing rate of childhood cancer cure and the risks of sequelae, long-term follow-up (FU) of survivors is a central issue. Several models have been proven far from satisfactory. Shared care FU is the result of collaboration between general practitioners (GPs) and cancer centers. We sought to demonstrate the feasibility of setting up a shared care program based on the patient-centered education of GPs and to evaluate the impact of this model in an intervention study.

      Read Full Article
    4. The importance of oncologists giving hope

      Previous article in Early View: Impact of shared care program in follow-up of childhood cancer survivors: An intervention study

      Previous article in Early View: Impact of shared care program in follow-up of childhood cancer survivors: An intervention study

      Next article in Early View: Infectious complications in children with acute lymphoblastic leukemia treated with the Taiwan Pediatric Oncology Group protocol: A 16-year tertiary single-institution experience

      Read Full Article
    5. ICR scientists awarded £1.5m precision medicine funding for targeted, less toxic childhood cancer treatments

      ICR scientists awarded £1.5m precision medicine funding for targeted, less toxic childhood cancer treatments

      Scientists from The Institute of Cancer Research, London, have been awarded £1.5 million by the charity Children with Cancer UK to advance precision medicine in the UK and improve cancer treatment for children and young adults.

      Read Full Article
      Mentions: Treatment
    6. Epidemiological analysis of childhood cancer in Japan based on population-based cancer registries, 1993-2009.

      Epidemiological analysis of childhood cancer in Japan based on population-based cancer registries, 1993-2009.

      Jpn J Clin Oncol. 2017 Mar 17;:1-4

      Authors: Ishihara H, Ohno Y, Fujii M, Hara J, Soda M

      Abstract Background: There are few recent data on trends in childhood cancer incidence using population-based cancer registries in Japan. Methods: This study comprised 6110 reported cases of patients aged 0-14 years who were diagnosed as having primary cancer between 1993 and 2009.

      Read Full Article
    7. Childhood cancer in small geographical areas and proximity to air-polluting industries.

      Childhood cancer in small geographical areas and proximity to air-polluting industries.

      Environ Res. 2017 Mar 16;156:63-73

      Authors: Ortega-García JA, López-Hernández FA, Cárceles-Álvarez A, Fuster-Soler JL, Sotomayor DI, Ramis R

      Abstract AIM: Pediatric cancer has been associated with exposure to certain environmental carcinogens. The purpose of this work is to analyse the relationship between environmental pollution and pediatric cancer risk.

      Read Full Article
    8. Gene regulatory mutation linked to rare childhood cancer

      Gene regulatory mutation linked to rare childhood cancer

      ( University of Wisconsin-Madison ) A single defect in a gene that codes for a histone -- a 'spool' that wraps idle DNA -- is linked to pediatric cancers in a study published today in the journal Science. 'Unlike most cancers that require multiple hits, we found that this particular mutation can form a tumor all by itself,' says Peter W. Lewis, an assistant professor of biomolecular chemistry in the School of Medicine and Public Health at the University of Wisconsin-Madison.

      Read Full Article
    9. Radiation And Immunotherapy Combination Can Destroy Both Primary And Secondary Tumors

      Turin, Italy: Radiation therapy not only kills cancer cells, but also helps to activate the immune system against their future proliferation. However, this immune response is often not strong enough to be able to cure tumours, and even when it is, its effect is limited to the area that has been irradiated.

      Read Full Article
    10. Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma

      LEUVEN, Belgium, May 2, 2016 /PRNewswire/ --

      Oncurious NV, an emerging oncology company focused on the development of innovative orphan drugs for the treatment of pediatric cancers, today announces it has initiated a Phase I/IIa study that will evaluate the safety and tolerability and...

      Read Full Article
      Mentions: NMTRC
    11. Using New Drug Screening Tool, UNC Researchers Identify Potential Treatments for Ewing Sarcoma

      In a first-of-its-kind-study, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that's most common in teens and young adults.

      Read Full Article
      Mentions: Genetics
    12. Splicing Alterations That Cause Resistance to CD19 CAR T-cell Therapy Identified

      Bottom Line: Resistance to CD19 CAR T-cell therapy, a type of immunotherapy that yields long-lasting remissions in many patients with B-cell leukemia, can be caused by CD19 splicing alterations, leading to loss of certain parts of the CD19 protein that are recognized by the CAR T cells. Journal in Which the Study was Published: Cancer Discovery, a journal of the American Association for Cancer Research

      Read Full Article
    13. Viral Therapy in Melanoma Clinical Trial Led by Rutgers Cancer Institute Physician-Scientist is Approved by FDA

      The U.S. Food and Drug Administration has approved an immunotherapy known as T-VEC that was the focus of a phase III melanoma clinical trial led by Rutgers Cancer Institute of New Jersey Associate Director for Clinical Science and Chief Surgical Officer Howard L. Kaufman, MD, FACS.

      Read Full Article
    1-24 of 43 1 2 »
  1. Categories

    1. Research:

      Cancer Cell, Case Report, Cells and Stem Cells, Clinical Research, Conferences, Disease Classification, Drug, Drug Delivery, Drug Resistance, Epigenetics and Epigenomics, General, Genetics, Genomics, Guidelines, Immune Therapy, Induction, Long Term Effects, Low / Intermediate Risk, Nanotechnology, Olfactory Neuroblastoma, Onco-Fertility, Oncogenesis, Other Cancers, Personalized Medicine, Pharma, Pre-Clinical, Prognostics, PubMed, Review, Small Molecules, Surgery, Survivorship, Trials, Tumor Biology, Virotherapy
    2. Business:

      Funding, IP, Pharma
    3. Non-Profit:

      Advocacy, Charity, Events, Foundation, Funding, Human Interest
    4. Press Release:

      Announcement, News, Pharma
    5. General:

      Adolescent and Young Adults, Bioethics, Blog, Burden of Treatment, Children & Families, Diagnosis and Detection, Epidemiology, Imaging, Incidence, Information, News, Overview of the Disease, Pain Control, Palliative Care, Psychosocial, Regulation, Side-Effects, Social, Supportive Care, Treatment
    6. Media:

      Audio, Blogs, Video
  2. Popular Articles

  3. Researches in the News

    1. (1 articles) LDH
  4. General Informations in the News

    1. (3 articles) Treatment